ID
16026
Beschrijving
Documentation part: Medical conditions & Lab A Randomised, Observer-blind, Multicentre, Non-inferiority, Comparative, Phase III Study of the Safety and Efficacy of Topical 1% SB-275833 Ointment, Applied Twice Daily for 5 Days, versus Topical 2% Sodium Fusidate Ointment Applied Three Times Daily for 7 Days in the Treatment of Adult and Paediatric Subjects with Impetigo. ClinicalTrials.gov Identifier: NCT00133874 Other Study ID Numbers: TOC100224 Responsible Party: GlaxoSmithKline
Trefwoorden
Versies (1)
- 26-06-16 26-06-16 -
Geüploaded op
26 juni 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Medical conditions & Lab Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874
Medical conditions & Lab Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874
Beschrijving
Electronically transferred Lab Data
Beschrijving
Date sample taken
Datatype
date
Maateenheden
- DDMONYYYY
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0200345
Beschrijving
Not done
Datatype
boolean
Alias
- UMLS CUI [1]
- C1272696
Beschrijving
Haem Lab type code
Datatype
text
Alias
- UMLS CUI [1,1]
- C0018941
- UMLS CUI [1,2]
- C0805701
Beschrijving
Chem Lab type code
Datatype
text
Alias
- UMLS CUI [1,1]
- C0005774
- UMLS CUI [1,2]
- C0805701
Beschrijving
Urin Lab type code
Datatype
text
Alias
- UMLS CUI [1,1]
- C0042014
- UMLS CUI [1,2]
- C0805701
Similar models
Medical conditions & Lab Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874
C0022658 (UMLS CUI [2])
C0851341 (UMLS CUI [2])
C0200345 (UMLS CUI [1,2])
C0805701 (UMLS CUI [1,2])
C0805701 (UMLS CUI [1,2])
C0805701 (UMLS CUI [1,2])